- Title: Subtitle
- Impact of baseline liver tumor burden on treatment outcomes with 177Lu-Dotatate in the Netter-1 study
- Creators
- J. Strosberg - H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USAE. Wolin - Mount Sinai HospitalJ. Yao - Univ Texas MD Anderson Canc Ctr, Houston, TX USAM. Kulke - Boston Medical CenterD. Bushnell - University of IowaM. Caplin - The Royal Free HospitalP. Baum - Zentralklinik Bad BerkaP. Kunz - Stanford UniversityT. Hobday - Mayo ClinicA. Hendifar - Cedars-Sinai Medical CenterE. Mittra - University of PortlandKjell Öberg - Uppsala UniversityP. Ruszniewski - Hop Beaujon, Clichy, FranceB. Polack - Adv Accelerator Applicat, New York, NY USAB. He - Adv Accelerator Applicat, Geneva, SwitzerlandP. Santoro - Adv Accelerator Applicat, New York, NY USAE. Krenning - Erasmus MC
- Resource Type
- Abstract
- Publication Details
- European journal of nuclear medicine and molecular imaging, Vol.45(Supplement 1), p.S60
- ISSN
- 1619-7070
- eISSN
- 1619-7089
- Comment
- Annual Congress of the European Association of Nuclear Medicine October 13 – 17, 2018 Düsseldorf, Germany. Eur J Nucl Med Mol Imaging 45 (Suppl 1), 1–844 (2018). https://doi.org/10.1007/s00259-018-4148-3
- Language
- English
- Date published
- 2018
- Academic Unit
- Radiology
- Record Identifier
- 9984320083102771
Abstract
Impact of baseline liver tumor burden on treatment outcomes with 177Lu-Dotatate in the Netter-1 study
European journal of nuclear medicine and molecular imaging, Vol.45(Supplement 1), p.S60
2018
Abstract
Details
Metrics
47 Record Views